SPONSORED RESEARCH AGREEMENT

9 Months Ended

Aug. 31, 2011

Sponsored Research Agreement [Abstract]

Sponsored Research Agreement [Text Block]

NOTE 14. SPONSORED RESEARCH AGREEMENT

On July 5, 2011, the Company, entered into a sponsored research agreement with the University Health Network (UHN), a not-for-profit corporation incorporated under the laws of Canada.  Under this agreement UHN will evaluate the Company’s product candidates, MCT-465 and MCT-485, in in vitro models for the treatment of primary liver cancer.  The mechanism of action of MCT-465 and MCT-485 and their potential selective effect on liver cancer stem cells will also be evaluated.  Under the terms of the agreement, the Company will retain exclusive access to the research findings and intellectual property resulting from the research activities preformed by UHN.